Prana announced successful results from the Phase IIa clinical trial of PBT2 in Early Alzheimer’s disease. Prana is a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders.
Prana Biotechnology Limited is hosting a conference call, to be simultaneously webcast Tuesday, February 26th at 5:00 pm Eastern Standard Time and Wednesday, February 27th at 9:00 a.m. Melbourne Time. This will involve a question and answer (Q&A) session that will follow management’s presentation.
Interested parties may partake in the conference call by dialing the following numbers five minutes before the call begins.
(800) 713-4218 US or Canada Toll Free
1 (617) 213-4870 for International callers
The live webcast of the conference call will be on the Prana website: http://www.pranabio.com. An archived webcast of the conference call will also be available for replay on the site. Interested parties may access the replay by dialing the following numbers:
(888) 286-8010 North America
1 (617) 801-6888 International
Conference ID Number: 1676682
Let us hear your thoughts below:
